1:Hemophilia A carriers X 1 = log 10 (AHF activity) X 2 = log 10 - PowerPoint PPT Presentation

Oct 30, 2022 •265 likes •322 views

1:Hemophilia A carriers X 1 = log 10 (AHF activity) X 2 = log 10 (AHF-like antigen) : n 1 = 30 ; : n 2 = 22 0 . 0065 0 . 2483 x (1) = x (2) = , 0 . 0390 0 . 0262

� � � � 1:Hemophilia A carriers X 1 = log 10 (AHF activity) X 2 = log 10 (AHF-like antigen) � � � : n 1 = 30 ; � � � : n 2 = 22 � � � � − 0 . 0065 − 0 . 2483 x (1) = x (2) = ¯ , ¯ − 0 . 0390 0 . 0262 � � 131 . 158 − 90 . 423 S − 1 = p − 90 . 423 108 . 147 – p. 1/
� 1:Hemophilia A carriers (1) � ′ � x 0 − 1 x (1) + ¯ x (1) − ¯ x (2) ) S − 1 x (2) ) W ( − → → − x 0 ) = 2(¯ p (¯ = − 2 . 01 < 0 , x 0 = ( − 0 . 210 , − 0 . 044) ′ � � � � . � � , − → – p. 2/
� 1:Hemophilia A carriers (2) � p 1 = 0 . 25 , p 2 = 0 . 75 � , � ′ � x 0 − 1 x (1) + ¯ x (1) − ¯ W ( − → − → x (2) ) S − 1 x (2) ) x 0 ) = 2(¯ p (¯ � 0 . 25 � = − 2 . 01 < ln = − 1 . 10 , 0 . 75 x 0 = ( − 0 . 210 , − 0 . 044) ′ � � � � . � � , − → – p. 3/
GBKkai 3-1

Recommend

Role of the Laboratory Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center

New Therapeutic Approaches to Hemophilia. The Role of the Laboratory Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center IRCCS C Granda Maggiore Hospital Foundation and Humanitas University Milano, Italy Coagulation

658 views • 46 slides

Carriers for Pneumatic Tube Systems 63 mm, 90 mm, 110 mm, 160 mm Carriers for Pneumatic Tube

Hanter Ingenjrsteknik AB Carriers for Pneumatic Tube Systems 63 mm, 90 mm, 110 mm, 160 mm Carriers for Pneumatic Tube Systems 63 mm Capsule 63 Red Cpl Art. 6035200 Flight bags 63 Art. 6035101, purple Art. 6035102, dark red Art. 6035103, dark

394 views • 5 slides

IP over Web-Avian Carriers (IPoWAC) Dan Ldtke Historical Context IP over Avian Carriers

IP over Web-Avian Carriers (IPoWAC) Dan Ldtke Historical Context IP over Avian Carriers RFC 1149 RFC 2549 Write/print IP datagram on paper Attach paper to avian carrier e.g. homing pigeon MTU depends in

662 views • 11 slides

WORLD FEDERATION OF HEMOPHILIA Mark Brooker, WFH Senior Public Policy Officer London July 2,

WORLD FEDERATION OF HEMOPHILIA Mark Brooker, WFH Senior Public Policy Officer London July 2, 2015 PATIEN TS PER SPEC TIVE The World Federation of Hemophilia (WFH), an international not-for-profit organization, was established in 1963.

460 views • 10 slides

Carriers and Foreign Air Carriers April 25, 2017 Requirement to Consult The Port Authority

PFC Consultation Meeting with Air Carriers and Foreign Air Carriers April 25, 2017 Requirement to Consult The Port Authority of New York and New Jersey (Port Authority) intends to submit an application to the Federal Aviation

195 views • 18 slides

SB-525, A NOVEL GENE THERAPY FOR TREATMENT OF HEMOPHILIA A Kathleen Meyer MPH, PhD, DABT Sangamo

SB-525, A NOVEL GENE THERAPY FOR TREATMENT OF HEMOPHILIA A Kathleen Meyer MPH, PhD, DABT Sangamo Therapeutics NorCal SOT Meeting October 24, 2019 2 We are committed to translating ground-breaking science into genomic medicines that transform

596 views • 34 slides

Hemophilia in the newborn without family history: Pattern of clinical presentation of three

See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/47728306 Hemophilia in the newborn without family history: Pattern of clinical presentation of three patients Article in Vojnosanitetski

404 views • 4 slides

Towards AAV5-mediated Gene Therapy for Hemophilia A with a Factor IX Variant that functions

Towards AAV5-mediated Gene Therapy for Hemophilia A with a Factor IX Variant that functions independently of FVIII Ying Poi Liu, PhD uniQure Biopharma B.V., Amsterdam, The Netherlands This presentation contains forward-looking statements. All

695 views • 20 slides

Private Insurance Changes and Resources and Self-Advocacy (Oh My!) Presented by: Michelle

HCCs 2019 Webinar Hemophilia Council of California series is sponsored Health Access, Advocacy , and Policy Webinar by: Private Insurance Changes and Resources and Self-Advocacy (Oh My!) Presented by: Michelle Rice, National Hemophilia

428 views • 18 slides

Appendix Potential target patient populations 2018 Oncology Hemophilia A Ophthalmology

Appendix Potential target patient populations 2018 Oncology Hemophilia A Ophthalmology Infectious diseasese Neuroscience Immunology 2 Herceptin + Perjeta, Tecentriq: HER2+ early Breast Cancer (eBC) 2018 estimates for number of patients 3

531 views • 49 slides

EMA Workshop on Hemophilia Registries Industry Perspectives July 01-02, 2015 - London Mary

EMA Workshop on Hemophilia Registries Industry Perspectives July 01-02, 2015 - London Mary Gustafson Vice President Medical and Regulatory Policy Plasma Protein Therapeutics Association www.pptaglobal.org Industry Collaborators Birgit

152 views • 13 slides

Using Zinc Finger Nucleases for Subjects with Hemophilia B NIH Recombinant DNA Advisory Committee

Gene editing and Targeted Integration Using Zinc Finger Nucleases for Subjects with Hemophilia B NIH Recombinant DNA Advisory Committee September 9, 2015 Nadia Ewing, MD, City of Hope John A. Zaia, MD, City of Hope Dale Ando, MD, Sangamo

575 views • 31 slides

Study funding: Janssen Alzheimer Immunotherapy and Pfizer Inc 42 2 Key Biomarker Secondary

Bapineuzumab Phase 3 trials in mild to moderate Alzheimers disease dementia in apolipoprotein E e 4 carriers (Study 302) and non-carriers (Study 301) CSF and Volumetric MRI Biomarkers Nick C Fox, MD, FRCP Professor of Neurology, MRC Senior

296 views • 26 slides

Alaska Exchange Carriers Association Alaska Exchange Carriers Association February 10, 2012 1

Alaska Exchange Carriers Association Alaska Exchange Carriers Association February 10, 2012 1 How do current access charges fit in with the FCC s proposed transition to bill and keep? FCCs proposed transition to bill and keep? The

887 views • 10 slides

UMBC A B M A L T F O U M B C I M Y O R T 1 (December 4, 2000 6:10 pm) I E S

Principles of VLSI Design Details of the MOS Transistor CMSC 491B/711 MOS Transistor Definitions n-type MOS: Majority carriers are electrons. p-type MOS: Majority carriers are holes. Positive/negative voltage applied to the gate (with respect

503 views • 22 slides

Study funding: Janssen Alzheimer Immunotherapy and Pfizer Inc 19 2 Results: Safety 20 3

Bapineuzumab Phase 3 trials in mild to moderate Alzheimers disease dementia in apolipoprotein E e 4 carriers (Study 302) and non-carriers (Study 301) Safety and PiB PET Amyloid Imaging Sperling R, Salloway S, Raskind M, Ferris S, Honig L,

495 views • 23 slides

Study funding: Janssen Alzheimer Immunotherapy and Pfizer Inc 2 2 Bapineuzumab Background A

Bapineuzumab Phase 3 trials in mild to moderate Alzheimers disease dementia in apolipoprotein E e 4 carriers (Study 302) and non-carriers (Study 301) Clinical Outcomes Salloway S, Sperling R, Raskind M, Ferris S, Honig L, Porsteinsson A,

598 views • 17 slides

Gateway Hemophilia Association & Missouri HTC Update Bridget Tyrey, Executive Director

Gateway Hemophilia Association & Missouri HTC Update Bridget Tyrey, Executive Director Questions Type questions into Q&A Phone: Text: (314) 482-5973 You may also submit questions through email info@GatewayHemophilia.org GHA

802 views • 17 slides

Single-Gene Disorders Oral Histology | Kristine Krafts, MD Objectives Explain how hemophilia

Single-Gene Disorders Oral Histology | Kristine Krafts, MD Objectives Explain how hemophilia is inherited, and describe its most common clinical features. Describe the inheritance pattern of neurofibromatosis, and explain two things

631 views • 31 slides

Terkel Andersen Chairman of the Board of Directors, EURORDIS Chairman, Danish Hemophilia Society

Terkel Andersen Chairman of the Board of Directors, EURORDIS Chairman, Danish Hemophilia Society eurordis.org 1 eurordis.org Photos submitted to the EURORDIS Photo Contest 3 eurordis.org EURORDIS Staff EURORDIS Summer School 2016 Rare

475 views • 14 slides

Why Are We Here? Access/ metro and backbone networks may belong to different carriers or

GIBSON: Global IP-Based Service-Oriented Network Ping Pan, Tom Nolle August 2006, IMS Workshop Why Are We Here? Access/ metro and backbone networks may belong to different carriers or business entities: Different technologies among

439 views • 12 slides

Malaysian Bulk Carriers Berhad 27 th Annual General Meeting Kuala Lumpur, 11 May 2018 MALAYSIAN

Malaysian Bulk Carriers Berhad 27 th Annual General Meeting Kuala Lumpur, 11 May 2018 MALAYSIAN BULK CARRIERS BERHAD (Company No:175953-W) Disclaimer The information contained in this presentation is for information purposes only, and does not

301 views • 13 slides

EXTERNAL VEST CARRIERS the Advantages of the Progressive Uniform INTRODUCTION Throughout the

EXTERNAL VEST CARRIERS the Advantages of the Progressive Uniform INTRODUCTION Throughout the country traditional Police uniforms have included a heavy duty belt that contains the equipment Officers need to perform out their daily tasks. This

578 views • 12 slides

The Post Patriarchal TC in America -- Women as Culture Carriers for Teaching Community

The Post Patriarchal TC in America -- Women as Culture Carriers for Teaching Community European Federation Therapeutic Communities Dublin, 2017 Naya Arbiter/Amity Foundation U.S.A. TC as a Revolution of Inclusion U.S. SOCIAL CONTEXT:

287 views • 28 slides